AR013261A1 - Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina - Google Patents
Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatinaInfo
- Publication number
- AR013261A1 AR013261A1 ARP980103700A ARP980103700A AR013261A1 AR 013261 A1 AR013261 A1 AR 013261A1 AR P980103700 A ARP980103700 A AR P980103700A AR P980103700 A ARP980103700 A AR P980103700A AR 013261 A1 AR013261 A1 AR 013261A1
- Authority
- AR
- Argentina
- Prior art keywords
- gelatin capsule
- camptotecine
- analogs
- pharmaceutical formulations
- release component
- Prior art date
Links
- 239000007903 gelatin capsule Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 abstract 1
- 229960000303 topotecan Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invencion se refiere a una composicion farmacéutica de topotecan estable en forma de una cápsula de gelatina. La invencion proporciona específicamenteuna matriz hidrofoba para la formulacion con toptecan HCl que se dispersa para minimizar cualquier reaccion química entre el fármaco activo, los excipientesy la humedad ambiental, con un componente de liberacion rápida y un componente de liberacion lenta.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90476197A | 1997-08-01 | 1997-08-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013261A1 true AR013261A1 (es) | 2000-12-13 |
Family
ID=25419727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103700A AR013261A1 (es) | 1997-08-01 | 1998-07-28 | Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR013261A1 (es) |
| AU (1) | AU8604598A (es) |
| CO (1) | CO4970695A1 (es) |
| WO (1) | WO1999006031A1 (es) |
| ZA (1) | ZA986877B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6281223B1 (en) * | 1999-04-13 | 2001-08-28 | Supergen, Inc. | Radioenhanced camptothecin derivative cancer treatments |
| AU2005222541B2 (en) * | 1999-08-10 | 2008-07-24 | Pharmacia & Upjohn S.P.A. | Pharmaceutical formulations in hydroxypropylmethylcellulose capsules |
| GB9918885D0 (en) * | 1999-08-10 | 1999-10-13 | Pharmacia & Upjohn Spa | Pharmaceutical formulations in hydroxypropymethycellulose capsules |
| GB9925127D0 (en) * | 1999-10-22 | 1999-12-22 | Pharmacia & Upjohn Spa | Oral formulations for anti-tumor compounds |
| AR046579A1 (es) | 2003-11-12 | 2005-12-14 | Smithkline Beecham Corp | Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica |
| GT200500310A (es) | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
| SA06270147B1 (ar) | 2005-06-09 | 2009-12-22 | نوفارتيس ايه جي | عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين |
| ITRM20050418A1 (it) * | 2005-08-04 | 2007-02-05 | Sigma Tau Ind Farmaceuti | Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina. |
| SG190859A1 (en) * | 2010-12-20 | 2013-07-31 | Colgate Palmolive Co | Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier |
| AU2010365804B2 (en) | 2010-12-20 | 2015-09-10 | Colgate-Palmolive Company | Non-aqueous oral care composition containing dental occlusion actives |
| AU2010365802B2 (en) | 2010-12-20 | 2015-07-09 | Colgate-Palmolive Company | Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier |
| US20220265659A1 (en) * | 2019-09-02 | 2022-08-25 | Inserm (Institut National De La Santé Et De Al Recherche Médicale) | Methods and compositions for treating pax6-deficiency related disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8904182D0 (en) * | 1989-02-23 | 1989-04-05 | Glaxo Canada | Pharmaceutical compositions |
| US5225404A (en) * | 1989-11-06 | 1993-07-06 | New York University | Methods of treating colon tumors with tumor-inhibiting camptothecin compounds |
| US5468754A (en) * | 1994-04-19 | 1995-11-21 | Bionumerik Pharmaceuticals, Inc. | 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof |
| US5677286A (en) * | 1995-04-27 | 1997-10-14 | The University Of Michigan | Glycosylated analogs of camptothecin |
-
1998
- 1998-07-28 AR ARP980103700A patent/AR013261A1/es unknown
- 1998-07-30 WO PCT/US1998/015908 patent/WO1999006031A1/en not_active Ceased
- 1998-07-30 AU AU86045/98A patent/AU8604598A/en not_active Abandoned
- 1998-07-31 CO CO98043769A patent/CO4970695A1/es unknown
- 1998-07-31 ZA ZA986877A patent/ZA986877B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999006031A1 (en) | 1999-02-11 |
| ZA986877B (en) | 1999-06-15 |
| AU8604598A (en) | 1999-02-22 |
| CO4970695A1 (es) | 2000-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2194732T3 (es) | Composiciones farmaceuticas orales de liberacion controlada de mesalazina. | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| UY27553A1 (es) | Formulaciones farmacéuticas de 5,7,14-triazatetraciclo(10.3.1.02,11.04,9)-hexadeca-2/11),3,5,7,9-pentaeno | |
| AR013261A1 (es) | Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina | |
| ES2002089T3 (es) | Nuevas formulaciones farmaceuticas con liberacion programada que contienen antiflogisticos. | |
| BR0206627A (pt) | Formulação farmacêutica | |
| RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
| BR0012869A (pt) | Forma de dosagem farmacêutica de componentes múltiplos | |
| ES2088312T3 (es) | Formulacion de liberacion controlada que contiene tramadol. | |
| PA8575701A1 (es) | Preparaciones acidas de insulina con estabilidad mejorada | |
| AR040722A1 (es) | Formulaciones y formas de dosificacion para la administracion controlada de topiramato | |
| AR038527A1 (es) | Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo | |
| AR011919A1 (es) | FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA | |
| IS7065A (is) | Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð | |
| AR034813A1 (es) | Composiciones farmaceuticas y uso de las mismas | |
| CO5540373A2 (es) | Composicion farmaceutica de liberacion sostenida | |
| UY25192A1 (es) | Formulación medicamentosa con liberación controlada de sustancia activa | |
| AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
| CO4410176A1 (es) | Formulaciones farmaceuticas de cefaclor | |
| CL2004001843A1 (es) | Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax | |
| AR025060A1 (es) | Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa | |
| AR017664A1 (es) | Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento | |
| CO4970832A1 (es) | Nuevas formulaciones y procesos para su fabricacion | |
| ECSP003685A (es) | Formulaciones orales de liberacion controlada | |
| BRPI0510694A (pt) | composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |